Assignee
PHANES THERAPEUTICS INC
US·10 granted patents·7 pending applications·24 citations·filing 2018–2025
Top patents by PatentIndex Score
17 records- 0189US11299550B2Anti-CD73 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Apr 12, 2022·9 cites·20 claims
- 0287US11555070B2Anti-claudin 18.2 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Jan 17, 2023·3 cites·16 claims
- 0386US12325745B2Anti-DLL3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2024·Granted Jun 10, 2025·0 cites·8 claims
- 0486US12037391B2Anti-DLL3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Jul 16, 2024·2 cites·9 claims
- 0586US11390679B2Anti-LAG-3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Jul 19, 2022·4 cites·17 claims
- 0684US11214615B2Anti-TIM-3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Jan 4, 2022·2 cites·18 claims
- 0778US11873335B2Anti-folate receptor 1 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Jan 16, 2024·1 cites·13 claims
- 0878US2025257127A1Anti-DLL3 Antibodies and Uses ThereofPHANES THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0975US11306151B2Anti-TIP-1 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Apr 19, 2022·1 cites·11 claims
- 1074US11365242B2Anti-apelin antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Jun 21, 2022·1 cites·36 claims
- 1173US11401329B2Anti-CD47 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Aug 2, 2022·1 cites·17 claims
- 1254US2025136703A1Anti-il13ra2 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1353US2023089926A1Antibodies Conjugated with Fatty Acid Molecules and Uses ThereofPHANES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1452US2024124574A1Bispecific Antibodies with Charge Pairs and Uses ThereofPHANES THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1552US2022411497A1Bispecific Antibodies with Alternatively Matched Interchain Cysteines and Uses ThereofPHANES THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1650US2022184127A1Humanized anti-dll3 chimeric antigen receptors and uses thereofPHANES THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1748US2023220107A1Anti-Tumor Associated Antigen Antibodies and Uses ThereofPHANES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PHANES THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →